Search
Black Diamond Therapeutics Inc
BDTXAdd to Watchlist
2.010USD
+0.170+9.24%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
114.46MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Black Diamond Therapeutics Inc is 7.00, ranking 80 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.72%, representing a quarter-over-quarter decrease of 24.33%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.87% of shares outstanding, with 0.05% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
T. Rowe Price Investment Management, Inc.
Versant Ventures
New Enterprise Associates (NEA)
Acadian Asset Management LLC
Dimensional Fund Advisors, L.P.
Marshall Wace LLP
Connor, Clark & Lunn Investment Management Ltd.
Invus Public Equities Advisors, LLC
Arrowstreet Capital, Limited Partnership
1
2